Literature DB >> 17505978

Silencing the PTEN gene is protective against neuronal death induced by human immunodeficiency virus type 1 Tat.

Tianyong Zhao1, Mary H Adams, Shi-Ping Zou, Nazira El-Hage, Kurt F Hauser, Pamela E Knapp.   

Abstract

Neurons are targets of toxicity induced by the human immunodeficiency virus (HIV)-1 protein Tat (transactivator of transcription). Exposure to Tat increases [Ca(2+)](i) in striatal neurons and activates multiple cell death pathways. In earlier studies the authors showed that Tat activated both caspase-3 and endonuclease-G, a caspase-independent effector of apoptosis, and that Tat-induced neurotoxicity was not attenuated by a caspase-3 inhibitor. Because Tat activates multiple, parallel death pathways, the authors attempted to reduce Tat-induced neurotoxicity by manipulating signaling pathways upstream of mitochondrial apoptotic events. PTEN (phosphatase and tensin homolog deleted on chromosome 10), a negative regulator of Akt/PKB (protein kinase B) phosphorylation, was chosen as a target for silencing. Akt/PKB activity directs multiple downstream pathways mediated by GSK3beta, BAD, forkhead transcription factors, nuclear factor kappa B (NFkappaB), and others, in a manner that promotes proliferation and survival. Striatal neurons were nucleofected with short interfering RNA (siRNA) vectors targeting PTEN, or a negative-control siRNA. Although Tat(1-86) significantly increased the death of neurons transfected with control construct by 72 h, PTEN-silenced neurons were completely protected. These findings indicate that Akt is a critical intermediary in the direct neurotoxicity induced by HIV-1 Tat, and identify Akt regulation as a possible therapeutic strategy for Tat-induced neurotoxicity in HIV encephalitis (HIVE).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505978     DOI: 10.1080/13550280701236841

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  57 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture.

Authors:  Torsten Falk; Shiling Zhang; Emilie L Erbe; Scott J Sherman
Journal:  J Comp Neurol       Date:  2006-01-10       Impact factor: 3.215

3.  Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons.

Authors:  L Mao; J Q Wang
Journal:  Brain Res Mol Brain Res       Date:  2001-01-31

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome.

Authors:  S A Lipton; H E Gendelman
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

5.  Critical implication of the (70-96) domain of human immunodeficiency virus type 1 Vpr protein in apoptosis of primary rat cortical and striatal neurons.

Authors:  Emmanuelle N Sabbah; Bernard P Roques
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

6.  HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity.

Authors:  S B Maggirwar; N Tong; S Ramirez; H A Gelbard; S Dewhurst
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

7.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

8.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

9.  Caspase cascades in human immunodeficiency virus-associated neurodegeneration.

Authors:  Gwenn A Garden; Samantha L Budd; Elena Tsai; Lisa Hanson; Marcus Kaul; Danielle M D'Emilia; Robert M Friedlander; Junying Yuan; Eliezer Masliah; Stuart A Lipton
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

10.  Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.

Authors:  Annadora J Bruce-Keller; Ashok Chauhan; Filomena O Dimayuga; Jillian Gee; Jeffrey N Keller; Avindra Nath
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

View more
  10 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons.

Authors:  Shiping Zou; Nazira El-Hage; Elizabeth M Podhaizer; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurovirol       Date:  2011-01-14       Impact factor: 2.643

3.  Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration.

Authors:  Lu Yang; Fang Niu; Honghong Yao; Ke Liao; Xufeng Chen; Yeonhee Kook; Rong Ma; Guoku Hu; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-01       Impact factor: 4.147

4.  NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.

Authors:  Matthew V Green; Stanley A Thayer
Journal:  J Neurosci       Date:  2016-11-03       Impact factor: 6.167

5.  Different Roles of Beclin1 in the Interaction Between Glia and Neurons after Exposure to Morphine and the HIV- Trans-Activator of Transcription (Tat) Protein.

Authors:  Jessica Lapierre; Mohan K M Karuppan; Marissa Perry; Myosotys Rodriguez; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2021-11-05       Impact factor: 7.285

6.  BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells.

Authors:  Alessandra Rosati; Kamel Khalili; Satish L Deshmane; Sujatha Radhakrishnan; Maria Pascale; M Caterina Turco; Liberato Marzullo
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

Review 7.  Role of Tat protein in HIV neuropathogenesis.

Authors:  Wenxue Li; Guanhan Li; Joseph Steiner; Avindra Nath
Journal:  Neurotox Res       Date:  2009-03-21       Impact factor: 3.911

8.  Molecular epigenetics, chromatin, and NeuroAIDS/HIV: translational implications.

Authors:  Paul Shapshak; Francesco Chiappelli; Deborah Commins; Elyse Singer; Andrew J Levine; Charurut Somboonwit; Alireza Minagar; Andras J Pellionisz
Journal:  Bioinformation       Date:  2008-10-07

9.  Incorporating the type and direction information in predicting novel regulatory interactions between HIV-1 and human proteins using a biclustering approach.

Authors:  Anirban Mukhopadhyay; Sumanta Ray; Ujjwal Maulik
Journal:  BMC Bioinformatics       Date:  2014-01-24       Impact factor: 3.169

10.  Silencing of PTEN inhibits the oxidative stress damage and hippocampal cell apoptosis induced by Sevoflurane through activating MEK1/ERK signaling pathway in infant rats.

Authors:  Tiejun Liu; Xiaoliu Dong; Bin Wang; Shubo Zhang; Jing Bai; Wei Ma; Xiaojing Zhao; Xiaotao Wang
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.